Neratinib useful for breast cancer regardless of trastuzumab use
Tremelimumab shows low but durable response rate in advanced melanoma
Breast cancer patients with positive sentinel nodes often not treated according to guidelines
Low-dose radiation for Hodgkin's lymphoma leaves kids at high risk for second cancers
Bortezomib effective for some indolent non-Hodgkin's lymphomas